These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

205 related items for PubMed ID: 12748304

  • 1. The effects of vinflunine, vinorelbine, and vinblastine on centromere dynamics.
    Okouneva T, Hill BT, Wilson L, Jordan MA.
    Mol Cancer Ther; 2003 May; 2(5):427-36. PubMed ID: 12748304
    [Abstract] [Full Text] [Related]

  • 2. Suppression of centromere dynamics by Taxol in living osteosarcoma cells.
    Kelling J, Sullivan K, Wilson L, Jordan MA.
    Cancer Res; 2003 Jun 01; 63(11):2794-801. PubMed ID: 12782584
    [Abstract] [Full Text] [Related]

  • 3. Mechanism of mitotic block and inhibition of cell proliferation by the semisynthetic Vinca alkaloids vinorelbine and its newer derivative vinflunine.
    Ngan VK, Bellman K, Hill BT, Wilson L, Jordan MA.
    Mol Pharmacol; 2001 Jul 01; 60(1):225-32. PubMed ID: 11408618
    [Abstract] [Full Text] [Related]

  • 4. Inhibition of centromere dynamics by eribulin (E7389) during mitotic metaphase.
    Okouneva T, Azarenko O, Wilson L, Littlefield BA, Jordan MA.
    Mol Cancer Ther; 2008 Jul 01; 7(7):2003-11. PubMed ID: 18645010
    [Abstract] [Full Text] [Related]

  • 5. Novel actions of the antitumor drugs vinflunine and vinorelbine on microtubules.
    Ngan VK, Bellman K, Panda D, Hill BT, Jordan MA, Wilson L.
    Cancer Res; 2000 Sep 15; 60(18):5045-51. PubMed ID: 11016627
    [Abstract] [Full Text] [Related]

  • 6. Antimitotic and tubulin-interacting properties of vinflunine, a novel fluorinated Vinca alkaloid.
    Kruczynski A, Barret JM, Etiévant C, Colpaert F, Fahy J, Hill BT.
    Biochem Pharmacol; 1998 Mar 01; 55(5):635-48. PubMed ID: 9515574
    [Abstract] [Full Text] [Related]

  • 7. Vinflunine, a new vinca alkaloid: cytotoxicity, cellular accumulation and action on the interphasic and mitotic microtubule cytoskeleton of PtK2 cells.
    Jean-Decoster C, Brichese L, Barret JM, Tollon Y, Kruczynski A, Hill BT, Wright M.
    Anticancer Drugs; 1999 Jul 01; 10(6):537-43. PubMed ID: 10885901
    [Abstract] [Full Text] [Related]

  • 8. Effects of vinblastine, podophyllotoxin and nocodazole on mitotic spindles. Implications for the role of microtubule dynamics in mitosis.
    Jordan MA, Thrower D, Wilson L.
    J Cell Sci; 1992 Jul 01; 102 ( Pt 3)():401-16. PubMed ID: 1506423
    [Abstract] [Full Text] [Related]

  • 9. Low concentrations of vinflunine induce apoptosis in human SK-N-SH neuroblastoma cells through a postmitotic G1 arrest and a mitochondrial pathway.
    Pourroy B, Carré M, Honoré S, Bourgarel-Rey V, Kruczynski A, Briand C, Braguer D.
    Mol Pharmacol; 2004 Sep 01; 66(3):580-91. PubMed ID: 15322250
    [Abstract] [Full Text] [Related]

  • 10. Exploring the mechanisms of action of the novel microtubule inhibitor vinflunine.
    Jordan MA, Horwitz SB, Lobert S, Correia JJ.
    Semin Oncol; 2008 Jun 01; 35(3 Suppl 3):S6-S12. PubMed ID: 18538179
    [Abstract] [Full Text] [Related]

  • 11. Vinflunine, the latest Vinca alkaloid in clinical development. A review of its preclinical anticancer properties.
    Kruczynski A, Hill BT.
    Crit Rev Oncol Hematol; 2001 Nov 01; 40(2):159-73. PubMed ID: 11682323
    [Abstract] [Full Text] [Related]

  • 12. Vinflunine, a novel microtubule inhibitor, suppresses calmodulin interaction with the microtubule-associated protein STOP.
    Makarov AA, Tsvetkov PO, Villard C, Esquieu D, Pourroy B, Fahy J, Braguer D, Peyrot V, Lafitte D.
    Biochemistry; 2007 Dec 25; 46(51):14899-906. PubMed ID: 18052208
    [Abstract] [Full Text] [Related]

  • 13. Vinflunine, a second generation novel Vinca Alkaloid with a distinctive pharmacological profile, now in clinical development and prospects for future mitotic blockers.
    Hill BT.
    Curr Pharm Des; 2001 Sep 25; 7(13):1199-212. PubMed ID: 11472262
    [Abstract] [Full Text] [Related]

  • 14. Vinorelbine in cancer therapy.
    Capasso A.
    Curr Drug Targets; 2012 Jul 25; 13(8):1065-71. PubMed ID: 22594474
    [Abstract] [Full Text] [Related]

  • 15. Mitotic arrest and anaphase aberrations induced by vinorelbine in hamster cells in vitro.
    González-Cid M, Cuello MT, Larripa I.
    Anticancer Drugs; 1997 Jun 25; 8(5):529-32. PubMed ID: 9215618
    [Abstract] [Full Text] [Related]

  • 16. Antiangiogenic concentrations of vinflunine increase the interphase microtubule dynamics and decrease the motility of endothelial cells.
    Pourroy B, Honoré S, Pasquier E, Bourgarel-Rey V, Kruczynski A, Briand C, Braguer D.
    Cancer Res; 2006 Mar 15; 66(6):3256-63. PubMed ID: 16540678
    [Abstract] [Full Text] [Related]

  • 17. Immunofluorescence study of the action of navelbine, vincristine and vinblastine on mitotic and axonal microtubules.
    Binet S, Chaineau E, Fellous A, Lataste H, Krikorian A, Couzinier JP, Meininger V.
    Int J Cancer; 1990 Aug 15; 46(2):262-6. PubMed ID: 2200754
    [Abstract] [Full Text] [Related]

  • 18. Mitotic block in HeLa cells by vinblastine: ultrastructural changes in kinetochore-microtubule attachment and in centrosomes.
    Wendell KL, Wilson L, Jordan MA.
    J Cell Sci; 1993 Feb 15; 104 ( Pt 2)():261-74. PubMed ID: 8505360
    [Abstract] [Full Text] [Related]

  • 19. Comparison of the aneugenic effect of vinorelbine and vincristine in cultured human lymphocytes.
    González-Cid M, Cuello MT, Larripa I.
    Mutagenesis; 1999 Jan 15; 14(1):63-6. PubMed ID: 10474823
    [Abstract] [Full Text] [Related]

  • 20. The microtubule poison vinorelbine kills cells independently of mitotic arrest and targets cells lacking the APC tumour suppressor more effectively.
    Klotz DM, Nelson SA, Kroboth K, Newton IP, Radulescu S, Ridgway RA, Sansom OJ, Appleton PL, Näthke IS.
    J Cell Sci; 2012 Feb 15; 125(Pt 4):887-95. PubMed ID: 22399804
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.